School of Graduate, Hebei Medical University, Shijiazhuang, Hebei Province, China.
Department of Cardiology Center, Hebei General Hospital, Shijiazhuang, Hebei Province, China.
J Interv Cardiol. 2022 Mar 12;2022:8994106. doi: 10.1155/2022/8994106. eCollection 2022.
Mortality after percutaneous coronary intervention (PCI) in ST-elevation myocardial infarction (STEMI) patients with cardiogenic shock (CS) remains high. However, the real-world risk factors for mortality in these patients are poorly defined.
The aim of this study is to establish a clinical prognostic nomogram for predicting in-hospital mortality after primary PCI in STEMI patients with CS.
This retrospective, multicenter, observational study included STEMI patients with CS who underwent PCI at 39 hospitals in Hebei Province from January 2018 to December 2019. A multivariate logistic regression model was used to identify the factors associated with in-hospital mortality. These factors were then incorporated into a nomogram and its performance was evaluated by discrimination, calibration, and clinical utility.
This study included 274 patients, among whom 179 died in hospital. Sex, random blood glucose on admission, ejection fraction after PCI, no-reflow, and intra-aortic balloon pump (IABP) were independently associated with in-hospital mortality (all < 0.05). In the training set, the nomogram showed a C-index of 0.819, goodness-of-fit of 0.08, and area under the receiver operating characteristic curve (AUC) of 0.819 (95%CI = 0.759-0.879). In the testing set, the C-index was 0.842, goodness-of-fit was 0.585, and AUC was 0.842 (95%CI = 0.715-0.970). The results indicate that the nomogram had good discrimination and good prediction accuracy and could achieve a good net benefit.
We established and validated a nomogram that provided individual prediction of in-hospital mortality for STEMI patients with CS after PCI in a Chinese population.
ST 段抬高型心肌梗死(STEMI)合并心原性休克(CS)患者经皮冠状动脉介入治疗(PCI)后的死亡率仍然很高。然而,这些患者死亡的真实世界风险因素尚未明确。
本研究旨在建立预测 STEMI 合并 CS 患者行直接 PCI 后住院死亡率的临床预后列线图。
这是一项回顾性、多中心、观察性研究,纳入了 2018 年 1 月至 2019 年 12 月河北省 39 家医院接受 PCI 的 STEMI 合并 CS 患者。采用多变量 logistic 回归模型确定与住院死亡率相关的因素。然后,将这些因素纳入列线图,并通过区分度、校准度和临床实用性对其进行评估。
本研究共纳入 274 例患者,其中 179 例院内死亡。性别、入院时随机血糖、PCI 后射血分数、无复流和主动脉内球囊反搏(IABP)与院内死亡率独立相关(均<0.05)。在训练集中,列线图的 C 指数为 0.819,拟合优度为 0.08,受试者工作特征曲线下面积(AUC)为 0.819(95%CI=0.759-0.879)。在验证集中,C 指数为 0.842,拟合优度为 0.585,AUC 为 0.842(95%CI=0.715-0.970)。结果表明,该列线图具有良好的区分度和预测准确性,能够实现良好的净获益。
我们建立并验证了一个列线图,可对中国人群中 STEMI 合并 CS 患者 PCI 后住院死亡率进行个体化预测。